Creecool Powder

Adult dose

1) Split dosage method: The prepared solution of 1L should be taken for 1 hour in the evening before the colonoscopy (250mL every 15 minutes) along with an additional 500mL of water. The next morning, the prepared solution of 1L should again be taken for 1 hour with an additional 500mL of water. This process must be completed at least 1 hour before the colonoscopy. 2) Non-split dosage method (evening): The prepared solution of 1L should be taken for 1 hour in the evening before the colonoscopy (250mL every 15 minutes), followed by an additional 1.5 hours later with a second 1L prepared solution for 1 hour with 1L of water afterward.

This medication may rarely cause systemic tonic-clonic seizures even in patients without a history of seizures, so patients with electrolyte imbalances or those taking corresponding high-risk medications should exercise caution. It should not be administered to patients with serious gastrointestinal diseases such as bowel obstruction, intestinal perforation, toxic colitis, etc., and should be used cautiously in patients with severe ulcerative colitis. The artificial sweetener aspartame included in this medication breaks down into phenylalanine, so it should not be taken by patients with phenylketonuria. Patients who have hypersensitivity to this medication or its components, have gastrointestinal obstruction, perforation, dehydration, severe heart failure, active cancer, severe mucosal injury diseases, etc., should not take this medication. Elderly patients, frail patients, patients with severe constipation or bowel stenosis, and patients with significantly impaired kidney function should use this medication cautiously. This medication can cause side effects such as hunger, hypokalemia, headache, dizziness, abdominal pain, nausea, vomiting, abdominal distension, fatigue, and more. If unusual symptoms occur, they should contact healthcare professionals immediately. Particularly in elderly patients, serious side effects such as gastrointestinal bleeding, esophageal perforation, and acute pulmonary edema have been reported, so caution is required. While administering this medication, the patient's bowel movement status should be closely monitored, and if abdominal distension or pain worsens, the rate of administration should be slowed or stopped, and appropriate examination should be performed. If symptoms of fluid or electrolyte imbalance occur, blood tests should be conducted to confirm the condition and appropriate treatment should be given. Patients with heart disease or a high risk of electrolyte abnormalities should undergo ECG and kidney function tests, and assessments are recommended before and after a colonoscopy. This medication may induce diarrhea, so adequate hydration is essential. The risk of bowel mucosal damage increases when used with irritant laxatives, so co-administration is not recommended. It is desirable to fast for at least 1 hour before administration and not to consume solid food during administration. The effects of this medication on driving or machine operation are not known, but caution is advised if unusual symptoms occur. This medication may interfere with the absorption of other oral medications, so it is advisable to avoid taking other medications within 1 hour before and after administration. Pregnant or breastfeeding women should only use this medication if diagnostic benefits outweigh the risks, as safety has not been established. Children should not be administered this medication, as its safety and effectiveness have not been established, and elderly patients may be more sensitive to the drug, so caution is needed. In the case of overdose, dehydration and severe electrolyte abnormalities may occur, so immediate medical attention is necessary for appropriate treatment. This medication should not have other ingredients or fragrances added before administration, and should be taken immediately after dissolving in water; any remaining solution should be discarded within 24 hours. Store in a place out of reach of children; the prepared solution should be covered and refrigerated, and must not be transferred to other containers.

Serious side effects

• Hives
• severe swelling (edema)
• chest tightness
• difficulty breathing
• cold sweat
• pallor
• seizures
• severe rash with high fever
• blisters
• skin peeling

Mild side effects

Hunger, hypophosphatemia, hypokalemia, sleep disturbances, dizziness, headaches, upper abdominal pain, abdominal pain, nausea, abdominal distension, anal discomfort, vomiting, dyspepsia, dysphagia, fatigue, thirst, tremors, discomfort, decreased bicarbonate in the blood, decreased calcium in the blood, hypercalcemia, decreased or increased chloride in the blood, increased phosphate in the blood, liver dysfunction, runny nose, dermatitis, rashes, itching, tremor, renal impairment, renal failure

This medication is susceptible to air and moisture, so it should be kept in a tightly sealed container. Also, it should be stored in a cool place, and it is important to maintain a temperature between 1 and 30 degrees Celsius.

Appearance

Product A: A white or light yellow powder with a lemon scent, contained in an aluminum foil pouch. Product B: A white crystalline or crystalline powder without an odor and with a sour taste, contained in an aluminum foil pouch.

Package unit

1) (Product A: 112.803g/package, Product B: 10.6g/package) × 2, bottle (1000mL) 2) (Product A: 56.402g/package, Product B: 5.3g/package) × 4, bottle (500mL)